Literature DB >> 27438100

The Case for a Revised Definition of Myocardial Infarction-The Ongoing Conundrum of Type 2 Myocardial Infarction vs Myocardial Injury.

Joseph S Alpert1, Kristian A Thygesen2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27438100     DOI: 10.1001/jamacardio.2016.0543

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  8 in total

Review 1.  High-sensitivity assays for troponin in patients with cardiac disease.

Authors:  Dirk Westermann; Johannes Tobias Neumann; Nils Arne Sörensen; Stefan Blankenberg
Journal:  Nat Rev Cardiol       Date:  2017-04-06       Impact factor: 32.419

2.  Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial.

Authors:  Christoph B Olivier; Hillary Mulder; William R Hiatt; W Schuyler Jones; F Gerry R Fowkes; Frank W Rockhold; Jeffrey S Berger; Iris Baumgartner; Peter Held; Brian G Katona; Lars Norgren; Juuso Blomster; Manesh R Patel; Kenneth W Mahaffey
Journal:  JAMA Cardiol       Date:  2019-01-01       Impact factor: 14.676

3.  Treatment and outcomes of type 2 myocardial infarction and myocardial injury compared with type 1 myocardial infarction.

Authors:  Nathaniel R Smilowitz; Pritha Subramanyam; Eugenia Gianos; Harmony R Reynolds; Binita Shah; Steven P Sedlis
Journal:  Coron Artery Dis       Date:  2018-01       Impact factor: 1.439

Review 4.  Assessment and classification of patients with myocardial injury and infarction in clinical practice.

Authors:  Andrew R Chapman; Philip D Adamson; Nicholas L Mills
Journal:  Heart       Date:  2016-11-02       Impact factor: 5.994

5.  Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): It's Time to Face Reality!

Authors:  Jacqueline E Tamis-Holland; Hani Jneid
Journal:  J Am Heart Assoc       Date:  2018-06-28       Impact factor: 5.501

6.  5th generation vs 4th generation troponin T in predicting major adverse cardiovascular events and all-cause mortality in patients hospitalized for non-cardiac indications: A cohort study.

Authors:  Vedant Gupta; Marc Paranzino; Talal Alnabelsi; Karam Ayoub; Joshua Eason; Andin Mullis; John R Kotter; Andrew Parks; Levi May; Sethabhisha Nerusu; Chen Dai; Daniel Cleland; Steve Wah Leung; Vincent Leigh Sorrell
Journal:  PLoS One       Date:  2021-02-09       Impact factor: 3.240

7.  High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction.

Authors:  Andrew R Chapman; Philip D Adamson; Anoop S V Shah; Atul Anand; Fiona E Strachan; Amy V Ferry; Kuan Ken Lee; Colin Berry; Iain Findlay; Anne Cruikshank; Alan Reid; Alasdair Gray; Paul O Collinson; Fred Apple; David A McAllister; Donogh Maguire; Keith A A Fox; Catalina A Vallejos; Catriona Keerie; Christopher J Weir; David E Newby; Nicholas L Mills
Journal:  Circulation       Date:  2019-10-07       Impact factor: 29.690

8.  Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury.

Authors:  Andrew R Chapman; Anoop S V Shah; Kuan Ken Lee; Atul Anand; Oliver Francis; Philip Adamson; David A McAllister; Fiona E Strachan; David E Newby; Nicholas L Mills
Journal:  Circulation       Date:  2017-11-17       Impact factor: 29.690

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.